Several studies have shown that CuB inhibits STAT3 signaling in various cancer models such as colorectal cancer [34], lung cancer [70], neuroblastoma [35], acute myeloid leukemia [71], pancreatic cancer [72] and breast cancer [36]. Here, STAT3 is linked to pancreatic neoplasm.